BRAF and papillary carcinoma: BRAF mutations and RET/PTC rearrangements are mutually exclusive in papillary carcinomas, both activating constitutively the RET/PTC–RAS–BRAF–MAPK pathway (Kimura et al, 2003; Soares et al, 2003).